Next Article in Journal
Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in Adults
Next Article in Special Issue
Role of Brachytherapy Boost in Clinically Localized Intermediate and High-Risk Prostate Cancer: Lack of Benefit in Patients with Very High-Risk Factors T3b–4 and/or Gleason 9–10
Previous Article in Journal
Targeting of Ubiquitin E3 Ligase RNF5 as a Novel Therapeutic Strategy in Neuroectodermal Tumors
Previous Article in Special Issue
Comparison of Clinical Outcomes of Radical Prostatectomy versus IMRT with Long-Term Hormone Therapy for Relatively Young Patients with High- to Very High-Risk Localized Prostate Cancer
 
 
Review

Article Versions Notes

Cancers 2022, 14(7), 1803; https://doi.org/10.3390/cancers14071803
Action Date Notes Link
article xml file uploaded 1 April 2022 15:24 CEST Original file -
article xml uploaded. 1 April 2022 15:24 CEST Update -
article pdf uploaded. 1 April 2022 15:24 CEST Version of Record -
article html file updated 1 April 2022 15:25 CEST Original file -
article xml file uploaded 1 April 2022 15:25 CEST Update -
article xml uploaded. 1 April 2022 15:25 CEST Update https://www.mdpi.com/2072-6694/14/7/1803/xml
article pdf uploaded. 1 April 2022 15:25 CEST Updated version of record https://www.mdpi.com/2072-6694/14/7/1803/pdf
article html file updated 1 April 2022 15:27 CEST Update -
article html file updated 2 August 2022 16:59 CEST Update https://www.mdpi.com/2072-6694/14/7/1803/html
Back to TopTop